Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Kleinberg

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|June 1, 1985
Primate mammary development. Effects of hypophysectomy, prolactin inhibition, and growth hormone administrationD L Kleinberg, W Niemann, E Flamm, et al.
Acta Neuropathologica|January 1, 1981
Immunohistochemical and electron-microscopic studies of functional and non-functional pituitary adenomas including one TSH secreting tumor in a thyrotoxic patientH Cravioto, T Fukaya, E A Zimmerman, et al.
Endocrinology|October 1, 1993
Evidence that the growth hormone receptor mediates differentiation and development of the mammary glandM Feldman, W Ruan, B C Cunningham, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1980
Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's diseaseD L Kleinberg, A Lieberman, J Todd, et al.
Journal of Clinical Psychopharmacology|February 6, 1999
Prolactin levels and adverse events in patients treated with risperidoneD L Kleinberg, J M Davis, R de Coster, et al.
The American Journal of Managed Care|February 24, 2001
Clinical and reimbursement issues in growth hormone use in adultsB M Biller, M L Vance, D L Kleinberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Evidence for a nonprolactin, non-growth-hormone mammary mitogen in the human pituitary glandC B Newman, H Cosby, H G Friesen, et al.
The New England Journal of Medicine|September 22, 1983
Pergolide for the treatment of pituitary tumors secreting prolactin or growth hormoneD L Kleinberg, A E Boyd, S Wardlaw, et al.
The Journal of Clinical Endocrinology and Metabolism|April 28, 2012
Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppressionS Tuvia, J Atsmon, S L Teichman, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Octreotide as primary therapy for acromegalyC B Newman, S Melmed, A George, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|June 1, 1985
Primate mammary development. Effects of hypophysectomy, prolactin inhibition, and growth hormone administrationD L Kleinberg, W Niemann, E Flamm, et al.
Acta Neuropathologica|January 1, 1981
Immunohistochemical and electron-microscopic studies of functional and non-functional pituitary adenomas including one TSH secreting tumor in a thyrotoxic patientH Cravioto, T Fukaya, E A Zimmerman, et al.
Endocrinology|October 1, 1993
Evidence that the growth hormone receptor mediates differentiation and development of the mammary glandM Feldman, W Ruan, B C Cunningham, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1980
Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's diseaseD L Kleinberg, A Lieberman, J Todd, et al.
Journal of Clinical Psychopharmacology|February 6, 1999
Prolactin levels and adverse events in patients treated with risperidoneD L Kleinberg, J M Davis, R de Coster, et al.
The American Journal of Managed Care|February 24, 2001
Clinical and reimbursement issues in growth hormone use in adultsB M Biller, M L Vance, D L Kleinberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Evidence for a nonprolactin, non-growth-hormone mammary mitogen in the human pituitary glandC B Newman, H Cosby, H G Friesen, et al.
The New England Journal of Medicine|September 22, 1983
Pergolide for the treatment of pituitary tumors secreting prolactin or growth hormoneD L Kleinberg, A E Boyd, S Wardlaw, et al.
The Journal of Clinical Endocrinology and Metabolism|April 28, 2012
Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppressionS Tuvia, J Atsmon, S L Teichman, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Octreotide as primary therapy for acromegalyC B Newman, S Melmed, A George, et al.
Pageof 6